{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:07:08Z","timestamp":1786122428110,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Projects of the General Programs of the National Natural Science Foundation of China","award":["No.82271979"],"award-info":[{"award-number":["No.82271979"]}]},{"name":"Investigator-initiated Clinical Trial and Transformation of Scientific Achievements, Henan Cancer Hospital","award":["ITTA-2404"],"award-info":[{"award-number":["ITTA-2404"]}]},{"name":"Henan Province Central Plains Talent Program (Nurturing talent Series","award":["No.RS0011"],"award-info":[{"award-number":["No.RS0011"]}]},{"name":"Henan Province Special Program for Clinical Research Physician Training","award":["D20240001"],"award-info":[{"award-number":["D20240001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-026-12566-9","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:31:28Z","timestamp":1777311088000},"page":"6874-6886","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Temporal lymph node imaging features for prognostic risk stratification in neoadjuvant immunotherapy for esophageal cancer: a multicenter study"],"prefix":"10.1007","volume":"36","author":[{"given":"Tiantian","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funing","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuju","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5296-220X","authenticated-orcid":false,"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"12566_CR1","doi-asserted-by":"publisher","unstructured":"Jiang W, Zhang B, Xu J, Xue L, Wang L (2025) Current status and perspectives of esophageal cancer: a comprehensive review. Cancer Commun (Lond) 45:281\u2013331. https:\/\/doi.org\/10.1002\/cac2.12645","DOI":"10.1002\/cac2.12645"},{"key":"12566_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H et al (2024) Cancer incidence and mortality in China, 2022. J Natl Cancer Cent 4:47\u201353. https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006","journal-title":"J Natl Cancer Cent"},{"key":"12566_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.21037\/acs.2019.01.04","volume":"8","author":"S van der Horst","year":"2019","unstructured":"van der Horst S, de Maat MFG, van der Sluis PC et al (2019) Extended thoracic lymph node dissection in robotic-assisted minimal invasive esophagectomy (RAMIE) for patients with superior mediastinal lymph node metastasis. Ann Cardiothorac Surg 8:218\u2013225. https:\/\/doi.org\/10.21037\/acs.2019.01.04","journal-title":"Ann Cardiothorac Surg"},{"key":"12566_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"12566_CR5","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1111\/1759-7714.13088","volume":"10","author":"W Ni","year":"2019","unstructured":"Ni W, Chen J, Xiao Z et al (2019) Adjuvant radiotherapy for stage pN1M0 esophageal squamous cell carcinoma: results from a Chinese two-center study. Thorac Cancer 10:1431\u20131440. https:\/\/doi.org\/10.1111\/1759-7714.13088","journal-title":"Thorac Cancer"},{"key":"12566_CR6","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1002\/ijc.34417","volume":"152","author":"T Boerner","year":"2023","unstructured":"Boerner T, Carr RA, Hsu M et al (2023) Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy. Int J Cancer 152:2109\u20132122. https:\/\/doi.org\/10.1002\/ijc.34417","journal-title":"Int J Cancer"},{"key":"12566_CR7","doi-asserted-by":"publisher","first-page":"e004291","DOI":"10.1136\/jitc-2021-004291","volume":"10","author":"J Liu","year":"2022","unstructured":"Liu J, Yang Y, Liu Z et al (2022) Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma. J Immunother Cancer 10:e004291. https:\/\/doi.org\/10.1136\/jitc-2021-004291","journal-title":"J Immunother Cancer"},{"key":"12566_CR8","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1097\/JS9.0000000000002011","volume":"111","author":"K Lan","year":"2025","unstructured":"Lan K, Yan X, Lei J et al (2025) Clinical outcomes and short-term survival of neoadjuvant immunochemotherapy for resectable esophageal cancer: a multicenter retrospective cohort study. Int J Surg 111:1547\u20131551. https:\/\/doi.org\/10.1097\/JS9.0000000000002011","journal-title":"Int J Surg"},{"key":"12566_CR9","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1097\/SLA.0000000000005627","volume":"278","author":"N Altorki","year":"2023","unstructured":"Altorki N, Mynard N, Nasar A et al (2023) Ten-year survival and recurrence patterns after three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 278:e43\u2013e50. https:\/\/doi.org\/10.1097\/SLA.0000000000005627","journal-title":"Ann Surg"},{"key":"12566_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4643-8","volume":"18","author":"J Wang","year":"2018","unstructured":"Wang J, Liu M, Shen J et al (2018) Diagnostic value of intraoperative ultrasonography in assessing thoracic recurrent laryngeal nerve lymph nodes in patients with esophageal cancer. BMC Cancer 18:737. https:\/\/doi.org\/10.1186\/s12885-018-4643-8","journal-title":"BMC Cancer"},{"key":"12566_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/sj.bjc.6604200","volume":"98","author":"EPM van Vliet","year":"2008","unstructured":"van Vliet EPM, Heijenbrok-Kal MH, Hunink MGM et al (2008) Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer 98:547\u2013557. https:\/\/doi.org\/10.1038\/sj.bjc.6604200","journal-title":"Br J Cancer"},{"key":"12566_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10388-021-00879-1","volume":"19","author":"M Watanabe","year":"2022","unstructured":"Watanabe M, Toh Y, Ishihara R et al (2022) Comprehensive registry of esophageal cancer in Japan, 2014. Esophagus 19:1\u201326. https:\/\/doi.org\/10.1007\/s10388-021-00879-1","journal-title":"Esophagus"},{"key":"12566_CR13","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","volume":"18","author":"L Seymour","year":"2017","unstructured":"Seymour L, Bogaerts J, Perrone A et al (2017) iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol 18:e143\u2013e152. https:\/\/doi.org\/10.1016\/S1470-2045(17)30074-8","journal-title":"Lancet Oncol"},{"key":"12566_CR14","doi-asserted-by":"publisher","first-page":"6116","DOI":"10.1007\/s00330-020-07572-4","volume":"31","author":"FHJ Elsholtz","year":"2021","unstructured":"Elsholtz FHJ, Asbach P, Haas M et al (2021) Introducing the node reporting and data system 1.0 (Node-RADS): a concept for standardized assessment of lymph nodes in cancer. Eur Radiol 31:6116\u20136124. https:\/\/doi.org\/10.1007\/s00330-020-07572-4","journal-title":"Eur Radiol"},{"key":"12566_CR15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s00330-022-08994-y","volume":"33","author":"S Yan","year":"2023","unstructured":"Yan S, Shi Y-J, Liu C et al (2023) Quantitative CT evaluation after two cycles of induction chemotherapy to predict prognosis of patients with locally advanced oesophageal squamous cell carcinoma before undergoing definitive chemoradiotherapy\/radiotherapy. Eur Radiol 33:380\u2013390. https:\/\/doi.org\/10.1007\/s00330-022-08994-y","journal-title":"Eur Radiol"},{"key":"12566_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/doab021","volume":"35","author":"E Hagens","year":"2022","unstructured":"Hagens E, Tukanova K, Jamel S et al (2022) Prognostic relevance of lymph node regression on survival in esophageal cancer: a systematic review and meta-analysis. Dis Esophagus 35:doab021. https:\/\/doi.org\/10.1093\/dote\/doab021","journal-title":"Dis Esophagus"},{"key":"12566_CR17","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1097\/SLA.0000000000003445","volume":"273","author":"S Urakawa","year":"2021","unstructured":"Urakawa S, Makino T, Yamasaki M et al (2021) Lymph node response to neoadjuvant chemotherapy as an independent prognostic factor in metastatic esophageal cancer. Ann Surg 273:1141\u20131149. https:\/\/doi.org\/10.1097\/SLA.0000000000003445","journal-title":"Ann Surg"},{"key":"12566_CR18","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.3390\/cancers14184436","volume":"14","author":"W Li","year":"2022","unstructured":"Li W, Le NN, Onishi N et al (2022) Diffusion-weighted MRI for predicting pathologic complete response in neoadjuvant immunotherapy. Cancers (Basel) 14:4436. https:\/\/doi.org\/10.3390\/cancers14184436","journal-title":"Cancers (Basel)"},{"key":"12566_CR19","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.1007\/s00259-022-05872-z","volume":"49","author":"X Wang","year":"2022","unstructured":"Wang X, Yang W, Zhou Q et al (2022) The role of 18F-FDG PET\/CT in predicting the pathological response to neoadjuvant PD-1 blockade in combination with chemotherapy for resectable esophageal squamous cell carcinoma. Eur J Nucl Med Mol Imaging 49:4241\u20134251. https:\/\/doi.org\/10.1007\/s00259-022-05872-z","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"12566_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.21037\/acs.2017.03.14","volume":"6","author":"TW Rice","year":"2017","unstructured":"Rice TW, Patil DT, Blackstone EH (2017) 8th edition AJCC\/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg 6:119\u2013130. https:\/\/doi.org\/10.21037\/acs.2017.03.14","journal-title":"Ann Cardiothorac Surg"},{"key":"12566_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"12566_CR22","doi-asserted-by":"publisher","first-page":"e0300173","DOI":"10.1371\/journal.pone.0300173","volume":"19","author":"T-H Pao","year":"2024","unstructured":"Pao T-H, Chen Y-Y, Chang W-L et al (2024) Lymph node volume predicts survival in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery. PLoS One 19:e0300173. https:\/\/doi.org\/10.1371\/journal.pone.0300173","journal-title":"PLoS One"},{"key":"12566_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.109547","volume":"51","author":"B Zhao","year":"2025","unstructured":"Zhao B, Wang Y-Q, Zhu H-T et al (2025) Integrating tumour and lymph node radiomics features for predicting disease-free survival in locally advanced esophageal squamous cell cancer after neoadjuvant chemotherapy and complete resection. Eur J Surg Oncol 51:109547. https:\/\/doi.org\/10.1016\/j.ejso.2024.109547","journal-title":"Eur J Surg Oncol"},{"key":"12566_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1200\/JCO.18.00032","volume":"37","author":"A Ogura","year":"2019","unstructured":"Ogura A, Konishi T, Cunningham C et al (2019) Neoadjuvant (chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3\/4 rectal cancer. J Clin Oncol 37:33\u201343. https:\/\/doi.org\/10.1200\/JCO.18.00032","journal-title":"J Clin Oncol"},{"key":"12566_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.6004\/jnccn.2023.7081","volume":"22","author":"EGM van Geffen","year":"2024","unstructured":"van Geffen EGM, Sluckin TC, Hazen S-MJA et al (2024) Value of size and malignant features of lateral lymph nodes in risk stratification at lateral local recurrence of rectal cancer: a national cohort study. J Natl Compr Cancer Netw 22:17\u201325. https:\/\/doi.org\/10.6004\/jnccn.2023.7081","journal-title":"J Natl Compr Cancer Netw"},{"key":"12566_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.6004\/jnccn.2023.0019","volume":"21","author":"JA Ajani","year":"2023","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ et al (2023) Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 21:393\u2013422. https:\/\/doi.org\/10.6004\/jnccn.2023.0019","journal-title":"J Natl Compr Canc Netw"},{"key":"12566_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1456193","volume":"15","author":"J Feng","year":"2024","unstructured":"Feng J, Wang L, Yang X, Chen Q (2024) Adjuvant immunotherapy after neoadjuvant immunochemotherapy and esophagectomy for esophageal squamous cell carcinoma: a real-world study. Front Immunol 15:1456193. https:\/\/doi.org\/10.3389\/fimmu.2024.1456193","journal-title":"Front Immunol"},{"key":"12566_CR28","doi-asserted-by":"publisher","first-page":"998","DOI":"10.21037\/atm-21-2539","volume":"9","author":"X Deng","year":"2021","unstructured":"Deng X, He W, Jiang Y et al (2021) The impact of adjuvant therapy on survival for node-negative esophageal squamous cell carcinoma: a propensity score-matched analysis. Ann Transl Med 9:998. https:\/\/doi.org\/10.21037\/atm-21-2539","journal-title":"Ann Transl Med"},{"key":"12566_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.annonc.2024.10.829","volume":"36","author":"F Lordick","year":"2025","unstructured":"Lordick F, Mauer ME, Stocker G et al (2025) Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and\/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study. Ann Oncol 36:197\u2013207. https:\/\/doi.org\/10.1016\/j.annonc.2024.10.829","journal-title":"Ann Oncol"},{"key":"12566_CR30","doi-asserted-by":"publisher","unstructured":"Naves AA, Gouvea G de L, Machado CVB et al (2025) MRI-detected extranodal extension as a marker of prostate cancer aggressiveness. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-025-11532-1","DOI":"10.1007\/s00330-025-11532-1"},{"key":"12566_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.709070","volume":"11","author":"Z Zhuang","year":"2021","unstructured":"Zhuang Z, Zhang Y, Wei M et al (2021) Magnetic resonance imaging evaluation of the accuracy of various lymph node staging criteria in rectal cancer: a systematic review and meta-analysis. Front Oncol 11:709070. https:\/\/doi.org\/10.3389\/fonc.2021.709070","journal-title":"Front Oncol"},{"key":"12566_CR32","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ejso.2020.09.005","volume":"47","author":"P Bhattacharya","year":"2021","unstructured":"Bhattacharya P, Mukherjee R (2021) Lymph node extracapsular extension as a marker of aggressive phenotype: classification, prognosis and associated molecular biomarkers. Eur J Surg Oncol 47:721\u2013731. https:\/\/doi.org\/10.1016\/j.ejso.2020.09.005","journal-title":"Eur J Surg Oncol"},{"key":"12566_CR33","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.cell.2022.04.019","volume":"185","author":"NE Reticker-Flynn","year":"2022","unstructured":"Reticker-Flynn NE, Zhang W, Belk JA et al (2022) Lymph node colonization induces tumor-immune tolerance to promote distant metastasis. Cell 185:1924\u20131942.e23. https:\/\/doi.org\/10.1016\/j.cell.2022.04.019","journal-title":"Cell"},{"key":"12566_CR34","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41577-023-00965-8","volume":"24","author":"P Cruz de Casas","year":"2024","unstructured":"Cruz de Casas P, Kn\u00f6pper K, Dey Sarkar R, Kastenm\u00fcller W (2024) Same yet different\u2014how lymph node heterogeneity affects immune responses. Nat Rev Immunol 24:358\u2013374. https:\/\/doi.org\/10.1038\/s41577-023-00965-8","journal-title":"Nat Rev Immunol"},{"key":"12566_CR35","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1097\/SLA.0000000000005214","volume":"277","author":"M Kloft","year":"2023","unstructured":"Kloft M, Ruisch JE, Raghuram G et al (2023) Prognostic significance of negative lymph node long axis in esophageal cancer: results from the randomized controlled UK MRC OE02 trial. Ann Surg 277:e320\u2013e331. https:\/\/doi.org\/10.1097\/SLA.0000000000005214","journal-title":"Ann Surg"},{"key":"12566_CR36","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","volume":"73","author":"AM Mandard","year":"1994","unstructured":"Mandard AM, Dalibard F, Mandard JC et al (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73:2680\u20132686","journal-title":"Cancer"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-026-12566-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-026-12566-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-026-12566-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T10:09:46Z","timestamp":1786097386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-026-12566-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["12566"],"URL":"https:\/\/doi.org\/10.1007\/s00330-026-12566-9","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The scientific guarantor of this publication is Yang Zhou.","order":1,"name":"Ethics","label":"Guarantor","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"One of the authors has significant statistical expertise: Qiuju Zhang (Health Management Centre, Harbin Medical University Cancer Hospital; Department of Biostatistics, School of Public Health, Harbin Medical University, Harbin, China).","order":3,"name":"Ethics","label":"Statistics and biometry","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":4,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Institutional Review Board approval was obtained. Ethics Committee of Harbin Medical University Cancer Hospital: IRB:2020-50-IIT, Ethics Committee of Henan Cancer Hospital: IRB: 2025-710-001.","order":5,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":6,"name":"Ethics","label":"Study subjects or cohorts overlap","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"order":7,"name":"Ethics","label":"Methodology","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}